Effect of Therapeutic Doses of Alisporivir on Methadone Pharmacokinetics in Healthy Subjects and Patients on Stable Methadone Maintenance Therapy

Trial Profile

Effect of Therapeutic Doses of Alisporivir on Methadone Pharmacokinetics in Healthy Subjects and Patients on Stable Methadone Maintenance Therapy

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Apr 2014

At a glance

  • Drugs Alisporivir (Primary) ; Methadone
  • Indications Drug dependence; Hepatitis C
  • Focus Pharmacokinetics
  • Sponsors Novartis Institutes for BioMedical Research
  • Most Recent Events

    • 06 May 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top